Argentinian mammarenavirus better known Junin virus Junín virus JUNV arenavirus Mammarenavirus genus causes Argentine hemorrhagic fever AHF The virus took original name city Junín around first cases infection reported Argentinian mammarenavirus negative sense ssRNA enveloped virion variable diameter nm The surface particle encompasses layer Tshaped glycoproteins extending nm outwards envelope important mediating attachment entry host cells The Argentinian mammarenavirus genome composed two singlestranded RNA molecules encoding two different genes ambisense orientation The two segments termed short S long L owing respective lengths The short segment around nucleotides length encodes nucleocapsid protein glycoprotein precursor GPC The GPC subsequently cleaved form two viral glycoproteins GP GP ultimately form Tshaped glycoprotein spike extends outwards viral envelope The long segment around nucleotides length encodes viral polymerase zincbinding protein The virus spread rodents A member genus Mammarenavirus Argentinian mammarenavirus characteristically causes Argentine hemorrhagic fever AHF AHF leads severe compromise vascular neurological immune systems mortality rate Symptoms disease conjunctivitis purpura petechiae occasionally sepsis The symptoms disease confusing condition mistaken different one especially first week resemble flu Since discovery Argentinian mammarenavirus geographical distribution pathogen although still confined Argentina expanded At time discovery Argentinian mammarenavirus confined area around km² At beginning region reported cases grew around km² The natural hosts Argentinian mammarenavirus rodents particularly Mus musculus Calomys spp Akodon azarae Direct rodenttohuman transmission takes place person makes direct contact excrement infected rodent occur ingestion contaminated food water inhalation particles urine direct contact open wound rodent feces An investigational US vaccine Candid developed US Army Medical Research Institute Infectious Disease USAMRIID Ft Detrick MD shown safe well tolerated effective reducing mortality morbidity due AHF The vaccine came XJ strain Argentinian mammarenavirus continually passaged total times newborn mouse brains total times along cloning FRhL cells Over volunteers Phase clinical trials developed antibodies Argentinian mammarenavirus developed adequate immune response specific Argentinian mammarenavirus Moreover large efficacy study among people individuals randomly selected take Candid individuals randomly selected take placebo resulted cases Juninlike infections cases placebo group This efficacy study resulted vaccine efficacy Currently Candid vaccine otherwise known Junin vaccine licensed Argentina regulatory agency Argentina Argentinian mammarenavirus endemic region People laboratories come constant contact Argentinian mammarenavirus also recommended take Junin vaccine prevent transmission 